rosuvastatinPapers
Papers about rosuvastatin
- papers
- 651
Newest first
351 to 400 of 651Every paper here, unless its row says otherwiseReturned by a PubMed search for rosuvastatin
Daily and intermittent rosuvastatin 5 mg therapy in statin intolerant patients: an observational study.
Current medical research and opinion2012PMID 22256801
One-year efficacy and safety of rosuvastatin + fenofibric acid combination therapy in patients with mixed dyslipidemia: evaluation of dose response.
American journal of cardiovascular drugs2012PMID 22263674
Non-lipid effects of rosuvastatin-fenofibrate combination therapy in high-risk Asian patients with mixed hyperlipidemia.
Atherosclerosis2012PMID 22269152
Renal safety of intensive cholesterol-lowering treatment with rosuvastatin: a retrospective analysis of renal adverse events among 40,600 participants in the rosuvastatin clinical development program.
Atherosclerosis2012PMID 22304793
Genetic determinants of statin-induced low-density lipoprotein cholesterol reduction: the Justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER) trial.
Circulation. Cardiovascular genetics2012PMID 22331829
Effect of rosuvastatin monotherapy and in combination with fenofibrate or omega-3 fatty acids on serum vitamin D levels.
Journal of cardiovascular pharmacology and therapeutics2012PMID 22431864
The effect of rosuvastatin on incident pneumonia: results from the JUPITER trial.
CMAJ2012PMID 22431901
Rosuvastatin improves pulse wave reflection by restoring endothelial function.
Microvascular research2012PMID 22484031
Galectin-3 predicts response to statin therapy in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA).
European heart journal2012PMID 22513778
On-treatment non-high-density lipoprotein cholesterol, apolipoprotein B, triglycerides, and lipid ratios in relation to residual vascular risk after treatment with potent statin therapy: JUPITER (justification for the use of statins in prevention: an intervention trial evaluating rosuvastatin).
Journal of the American College of Cardiology2012PMID 22516441
Effects of metformin plus rosuvastatin on hyperandrogenism in polycystic ovary syndrome patients with hyperlipidemia and impaired glucose tolerance.
Journal of endocrinological investigation2012PMID 22522778
Rosuvastatin and the JUPITER trial: critical appraisal of a lifeless planet in the galaxy of primary prevention.
International journal of occupational and environmental health2012PMID 22550699
Rosuvastatin might have an effect on C-reactive protein but not on rheumatoid disease activity: Tayside randomized controlled study.
Scottish medical journal2012PMID 22555227
Effect of rosuvastatin on ROCK activity, endothelial function, and inflammation in Asian patients with atherosclerosis.
Internal medicine (Tokyo, Japan)2012PMID 22687786
The ability of high dose rosuvastatin to improve plaque composition in non-intervened coronary arteries: rationale and design of the Integrated Biomarker and Imaging Study-3 (IBIS-3).
EuroIntervention2012PMID 22717926
Effects of rosuvastatin versus pravastatin on low-density lipoprotein diameter in HIV-1-infected patients receiving ritonavir-boosted protease inhibitor.
AIDS (London, England)2012PMID 22739396
Single-dose, 2-way crossover, bioequivalence study of two rosuvastatin formulations in normal healthy subjects under fasting conditions.
International journal of clinical pharmacology and therapeutics2012PMID 22762855
The high-dose rosuvastatin once weekly study (the HD-ROWS).
Journal of clinical lipidology2012PMID 22836073
Low-dose rosuvastatin improves the functional and morphological markers of atherosclerosis in asymptomatic postmenopausal women with dyslipidemia.
Menopause (New York, N.Y.)2012PMID 22850442
Effect of high-dose rosuvastatin loading before percutaneous coronary intervention in female patients with non-ST-segment elevation acute coronary syndrome.
Chinese medical journal2012PMID 22882843
Effect of rosuvastatin on the echolucency of the common carotid intima-media in low-risk individuals: the METEOR trial.
Journal of the American Society of Echocardiography2012PMID 22884641
Rosuvastatin-induced high-density lipoprotein changes in patients who underwent percutaneous coronary intervention for non-ST-segment elevation acute coronary syndrome.
Journal of cardiology2012PMID 22884684
Effect of rosuvastatin monotherapy or in combination with fenofibrate or ω-3 fatty acids on lipoprotein subfraction profile in patients with mixed dyslipidaemia and metabolic syndrome.
International journal of clinical practice2012PMID 22897461
Rosuvastatin slows the development of diastolic dysfunction in calcific aortic stenosis.
The Journal of heart valve disease2012PMID 22953672
Total cholesterol content of erythrocyte membranes is associated with the severity of coronary artery disease and the therapeutic effect of rosuvastatin.
Upsala journal of medical sciences2012PMID 23009223
Genome-wide association study evaluating lipoprotein-associated phospholipase A2 mass and activity at baseline and after rosuvastatin therapy.
Circulation. Cardiovascular genetics2012PMID 23118302
The predictive value of galectin-3 for mortality and cardiovascular events in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA).
American heart journal2012PMID 23194488
Attainment of goal/desirable lipid levels in patients with mixed dyslipidemia after 12 weeks of treatment with fenofibric acid and rosuvastatin combination therapy: a pooled analysis of controlled studies.
Journal of clinical lipidology2012PMID 23312049
Why did high-dose rosuvastatin not improve cardiac remodeling in chronic heart failure? Mechanistic insights from the UNIVERSE study.
International journal of cardiology2011PMID 20085851
High-dose rosuvastatin in chronic heart failure promotes vasculogenesis, corrects endothelial function, and improves cardiac remodeling--results from a randomized, double-blind, and placebo-controlled study.
International journal of cardiology2011PMID 20236716
Open-label, ascending dose, prospective cohort study evaluating the antiviral efficacy of Rosuvastatin therapy in serum and lipid fractions in patients with chronic hepatitis C.
Journal of viral hepatitis2011PMID 20367801
STATIN-D study: comparison of the influences of rosuvastatin and fluvastatin treatment on the levels of 25 hydroxyvitamin D.
Cardiovascular therapeutics2011PMID 20370794
12-month follow-up results of high dose rosuvastatin loading before percutaneous coronary intervention in patients with acute coronary syndrome.
International journal of cardiology2011PMID 20471117
Effects of pravastatin and rosuvastatin on the generation of adiponectin in the visceral adipose tissue in patients with coronary artery disease.
Fundamental & clinical pharmacology2011PMID 20608995
Rosuvastatin induces apoptosis in CD4(+)CD28 (null) T cells in patients with acute coronary syndromes.
Clinical research in cardiology2011PMID 20852871
Rosuvastatin for primary prevention in patients with European systematic coronary risk evaluation risk ≥ 5% or Framingham risk >20%: post hoc analyses of the JUPITER trial requested by European health authorities.
European heart journal2011PMID 20971747
Effects of atorvastatin and rosuvastatin on thromboxane-dependent platelet activation and oxidative stress in hypercholesterolemia.
Atherosclerosis2011PMID 21056418
Aleglitazar, a balanced PPARα/γ agonist, has no clinically relevant pharmacokinetic interaction with high-dose atorvastatin or rosuvastatin.
Expert opinion on investigational drugs2011PMID 21114416
Effects of rosuvastatin and allopurinol on circulating endothelial progenitor cells in patients with congestive heart failure: the impact of inflammatory process and oxidative stress.
Atherosclerosis2011PMID 21122851
Comparison of effects of rosuvastatin and atorvastatin on plaque regression in Korean patients with untreated intermediate coronary stenosis.
Circulation journal2011PMID 21157106
Achievement of lipid targets with the combination of rosuvastatin and fenofibric Acid in patients with type 2 diabetes mellitus.
Cardiovascular drugs and therapy2011PMID 21174145
A crossover study of rosuvastatin and pitavastatin in patients with type 2 diabetes.
Advances in therapy2011PMID 21222064
Early intervention with rosuvastatin decreases the lipid components of the plaque in acute coronary syndrome: analysis using integrated backscatter IVUS (ELAN study).
Circulation journal2011PMID 21266787
Evaluating the effectiveness of rosuvastatin in preventing the progression of diastolic dysfunction in aortic stenosis: A substudy of the aortic stenosis progression observation measuring effects of rosuvastatin (ASTRONOMER) study.
Cardiovascular ultrasound2011PMID 21299902
No effect of rosuvastatin in the zoledronate-induced acute-phase response.
Calcified tissue international2011PMID 21305270
Effects of rosuvastatin on vascular biomarkers and carotid atherosclerosis in lupus: a randomized, double-blind, placebo-controlled trial.
Arthritis care & research2011PMID 21309005
High doses of rosuvastatin are superior to low doses of rosuvastatin plus fenofibrate or n-3 fatty acids in mixed dyslipidemia.
Lipids2011PMID 21327725
Switching from statin monotherapy to ezetimibe/simvastatin or rosuvastatin modifies the relationships between apolipoprotein B, LDL cholesterol, and non-HDL cholesterol in patients at high risk of coronary disease.
Clinical biochemistry2011PMID 21349260
Combining rosuvastatin with sartans of different peroxisome proliferator-activated receptor-γ activating capacity is not associated with different changes in low-density lipoprotein subfractions and plasma lipoprotein-associated phospholipase A₂.
Metabolic syndrome and related disorders2011PMID 21352079
Cardiovascular event reduction and adverse events among subjects attaining low-density lipoprotein cholesterol <50 mg/dl with rosuvastatin. The JUPITER trial (Justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin).
Journal of the American College of Cardiology2011PMID 21492764